These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24454857)

  • 1. Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.
    Loebel M; Strohschein K; Giannini C; Koelsch U; Bauer S; Doebis C; Thomas S; Unterwalder N; von Baehr V; Reinke P; Knops M; Hanitsch LG; Meisel C; Volk HD; Scheibenbogen C
    PLoS One; 2014; 9(1):e85387. PubMed ID: 24454857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
    Loebel M; Eckey M; Sotzny F; Hahn E; Bauer S; Grabowski P; Zerweck J; Holenya P; Hanitsch LG; Wittke K; Borchmann P; Rüffer JU; Hiepe F; Ruprecht K; Behrends U; Meindl C; Volk HD; Reimer U; Scheibenbogen C
    PLoS One; 2017; 12(6):e0179124. PubMed ID: 28604802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome.
    Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
    In Vivo; 2004; 18(2):101-6. PubMed ID: 15113035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
    Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response?
    Manian FA
    Clin Infect Dis; 1994 Sep; 19(3):448-53. PubMed ID: 7811864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
    Joncas JH; Wills A; Reece E; Fox Z
    Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets.
    Guerreiro M; Na IK; Letsch A; Haase D; Bauer S; Meisel C; Roemhild A; Reinke P; Volk HD; Scheibenbogen C
    Eur J Immunol; 2010 Jun; 40(6):1566-76. PubMed ID: 20232341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset.
    Lerner AM; Ariza ME; Williams M; Jason L; Beqaj S; Fitzgerald JT; Lemeshow S; Glaser R
    PLoS One; 2012; 7(11):e47891. PubMed ID: 23155374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers.
    Watt T; Oberfoell S; Balise R; Lunn MR; Kar AK; Merrihew L; Bhangoo MS; Montoya JG
    J Med Virol; 2012 Dec; 84(12):1967-74. PubMed ID: 23080504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome.
    Ruiz-Pablos M; Paiva B; Montero-Mateo R; Garcia N; Zabaleta A
    Front Immunol; 2021; 12():656797. PubMed ID: 34867935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus (EBV) and the chronic fatigue syndrome: normal virus load in blood and normal immunologic reactivity in the EBV regression assay.
    Swanink CM; van der Meer JW; Vercoulen JH; Bleijenberg G; Fennis JF; Galama JM
    Clin Infect Dis; 1995 May; 20(5):1390-2. PubMed ID: 7620030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of variations in levels of Epstein-Barr Virus (EBV) antigen and adaptive immune response during chronic active EBV infection in children.
    Xing Y; Song HM; Wei M; Liu Y; Zhang YH; Gao L
    J Immunotoxicol; 2013; 10(4):387-92. PubMed ID: 23418935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome.
    Cameron B; Flamand L; Juwana H; Middeldorp J; Naing Z; Rawlinson W; Ablashi D; Lloyd A
    J Med Virol; 2010 Oct; 82(10):1684-8. PubMed ID: 20827765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
    Blomberg J; Rizwan M; Böhlin-Wiener A; Elfaitouri A; Julin P; Zachrisson O; Rosén A; Gottfries CG
    Front Immunol; 2019; 10():1946. PubMed ID: 31475007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired.
    Cárdenas D; Vélez G; Orfao A; Herrera MV; Solano J; Olaya M; Uribe AM; Saavedra C; Duarte M; Rodríguez M; López M; Fiorentino S; Quijano S
    Clin Exp Immunol; 2015 Nov; 182(2):173-83. PubMed ID: 26174440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome.
    Sairenji T; Yamanishi K; Tachibana Y; Bertoni G; Kurata T
    Intervirology; 1995; 38(5):269-73. PubMed ID: 8724857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.
    Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A;
    J Infect Dis; 2006 Mar; 193(5):664-71. PubMed ID: 16453261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBV.
    Brousset P; Drouet E; Schlaifer D; Icart J; Payen C; Meggetto F; Marchou B; Massip P; Delsol G
    AIDS; 1994 May; 8(5):583-90. PubMed ID: 7914731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients.
    Petrova M; Muhtarova M; Nikolova M; Magaev S; Taskov H; Nikolovska D; Krastev Z
    World J Gastroenterol; 2006 Sep; 12(35):5711-6. PubMed ID: 17007027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.